ESR1 and breast cancer: Similar to NPB reported earlier in estrogen receptor (ER) + BC cell lines13, western blot results showed that single treatment with NCK alone did not affect the levels of phosphorylated nor total protein of components of MAPK or PI3K/AKT pathways in TNBC cells (Fig. 7f, Supplementary Fig. 14B).